Journal Article Summary
The article investigates the continuation rates of two types of intrauterine devices (IUDs)—the copper IUD and the levonorgestrel IUD—over a five-year period. This topic is significant because IUDs are a popular form of long-acting reversible contraception, and understanding their effectiveness and user retention can help improve reproductive health options for women. Previous studies have shown conflicting results regarding how long women continue using these devices, making it essential to explore factors influencing their use and discontinuation.
In this study, researchers analyzed data from 1,164 women who had IUDs placed at an urban medical center. They focused on the continuation rates of the levonorgestrel IUD compared to the copper IUD, as well as the factors associated with discontinuation and the rates of pregnancy and expulsion. The findings revealed that at two years, 64.9% of levonorgestrel IUD users continued using their device, compared to 57.7% of copper IUD users. By four years, the continuation rates were 45.1% for levonorgestrel users and 32.6% for copper users, indicating a significant difference. Additionally, copper IUD users experienced higher rates of expulsion and pregnancy within the first year of use.
The study has some limitations, including a high rate of loss to follow-up and reliance on medical records, which may not capture all reasons for discontinuation. Patients should be aware that while IUDs are effective contraceptives, individual experiences may vary, and discontinuation can occur for various reasons. It is advisable for readers to discuss their contraceptive options, including the potential benefits and drawbacks of IUDs, with a healthcare professional to make informed decisions about their reproductive health.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Phillips Sharon J., Hofler Lisa G., Modest Anna M., Harvey Lara F. B., Wu Lily H., Hacker Michele R.. Continuation of copper and levonorgestrel intrauterine devices: a retrospective cohort study. American journal of obstetrics and gynecology 2017. DOI: 10.1016/j.ajog.2017.03.005. PMID: 28315664. PMCID: PMC5810132.
Featured Pill Pals Product
My Way (Levonorgestrel) 1.5 mg Tablet - Generic For Plan B and Morning After Pill --- Lupin Pharma
My Way (Levonorgestrel) 1.5 mg Tablet - Generic For Plan B and Morning After Pill is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
